Antibody drug conjugate (ADC)
搜索文档
OS Therapies (NYSEAM:OSTX) 2025 Conference Transcript
2025-12-12 00:32
OS Therapies (NYSEAM:OSTX) 2025 Conference December 11, 2025 10:30 AM ET Company ParticipantsHarrison Seidner - Head of Investor RelationsOperatorHello and welcome to Virtual Investor Conferences. On behalf of OTC Markets, we are very pleased you have joined us for the Life Science Investor Forum. Our next presentation of the day is from OS Therapies. Please note you may submit questions for the presenter in the box to the left of the slides. You can also view a company's availability for a one-on-one meeti ...